Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 7
1946 20
1947 32
1948 44
1949 37
1950 32
1951 45
1952 30
1953 52
1954 69
1955 79
1956 91
1957 74
1958 78
1959 77
1960 108
1961 137
1962 208
1963 234
1964 269
1965 238
1966 210
1967 297
1968 359
1969 342
1970 388
1971 417
1972 508
1973 427
1974 480
1975 337
1976 314
1977 299
1978 362
1979 361
1980 444
1981 456
1982 492
1983 432
1984 258
1985 366
1986 426
1987 485
1988 481
1989 502
1990 419
1991 377
1992 360
1993 480
1994 430
1995 503
1996 543
1997 574
1998 707
1999 886
2000 1115
2001 1356
2002 1337
2003 1535
2004 1570
2005 1868
2006 1886
2007 2043
2008 2237
2009 2349
2010 2567
2011 2801
2012 2892
2013 2745
2014 2720
2015 2663
2016 2399
2017 2266
2018 2240
2019 2307
2020 2387
2021 2276
2022 1580
2023 596
2024 625

Text availability

Article attribute

Article type

Publication date

Search Results

61,355 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.
Kaul I, Sawchak S, Correll CU, Kakar R, Breier A, Zhu H, Miller AC, Paul SM, Brannan SK. Kaul I, et al. Lancet. 2024 Jan 13;403(10422):160-170. doi: 10.1016/S0140-6736(23)02190-6. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104575 Clinical Trial.
5-HT1F agonists.
Steel SJ. Steel SJ. Handb Clin Neurol. 2024;199:43-50. doi: 10.1016/B978-0-12-823357-3.00032-X. Handb Clin Neurol. 2024. PMID: 38307661 Review.
Octenidin „knackt“ den Biofilm.
Facharztmagazine R. Facharztmagazine R. MMW Fortschr Med. 2024 Mar;166(5):82. doi: 10.1007/s15006-024-3764-z. MMW Fortschr Med. 2024. PMID: 38514576 German. No abstract available.
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer.
Slamon DJ, Diéras V, Rugo HS, Harbeck N, Im SA, Gelmon KA, Lipatov ON, Walshe JM, Martin M, Chavez-MacGregor M, Bananis E, Gauthier E, Lu DR, Kim S, Finn RS. Slamon DJ, et al. J Clin Oncol. 2024 Mar 20;42(9):994-1000. doi: 10.1200/JCO.23.00137. Epub 2024 Jan 22. J Clin Oncol. 2024. PMID: 38252901 Free PMC article. Clinical Trial.
Preventive Treatment of Migraine.
Lipton RB. Lipton RB. Continuum (Minneap Minn). 2024 Apr 1;30(2):364-378. doi: 10.1212/CON.0000000000001418. Continuum (Minneap Minn). 2024. PMID: 38568488
Sotorasib in KRASG12C mutated lung cancer.
Olivier T, Prasad V. Olivier T, et al. Lancet. 2024 Jan 13;403(10422):145. doi: 10.1016/S0140-6736(23)02035-4. Lancet. 2024. PMID: 38218611 No abstract available.
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, Gutierrez Calderon V, Johnson ML, Madroszyk-Flandin A, Garon EB, He K, Planchard D, Reck M, Popat S, Herbst RS, Leal TA, Shazer RL, Yan X, Harrigan R, Peters S; SAPPHIRE Investigators. Borghaei H, et al. Ann Oncol. 2024 Jan;35(1):66-76. doi: 10.1016/j.annonc.2023.10.004. Epub 2023 Oct 20. Ann Oncol. 2024. PMID: 37866811 Clinical Trial.
61,355 results
You have reached the last available page of results. Please see the User Guide for more information.